FDA Publishes Internal Evaluation of Infant Formula Response

In May, FDA Commissioner Robert M. Califf, M.D., requested an internal agency review of the FDA’s actions related to multiple reports of Cronobacter in infants, the temporary shutdown of Abbot Nutrition’s facility in Sturgis, Michigan, and confounding issues that led to a shortage of infant formulas. On September 20, the FDA released the report, “FDA... Continue Reading